SBIR-STTR Award

Vasodilation Needle for Trans-Radial Access
Award last edited on: 2/5/2021

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$376,567
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
William Combs

Company Information

3DT Holdings LLC

11107 Roselle Street Suite 213
San Diego, CA 92121
   (317) 274-8337
   gkassab@3dtholdings.com
   www.3dtholdings.com
Location: Single
Congr. District: 52
County: San Diego

Phase I

Contract Number: 1R43HL149449-01A1
Start Date: 8/26/2020    Completed: 8/25/2021
Phase I year
2020
Phase I Amount
$376,567
The number of percutaneous arterial access procedures using the transradial access (TRA) approach is growing rapidly in the US. Interventionalists are adopting the TRA technique due to lower risks associated with bleeding and no need for active vascular closure devices. TRA catheterization also satisfies patients because of increased comfort and mobility. Same-day discharge is generally possible, which lowers costs for patients and health insurance companies. Radial artery spasm (RAS) is the most common complication encountered with the TRA technique, however, making access difficult and/or causing sheath entrapment. RAS can be painful for patients and is difficult for interventionalists to manage. Various pharmacological agents are used, but there are two problems with that strategy. First, there is no generally accepted drug regimen with proven efficacy in treating RAS. Second, pharmacological treatment is initiated only after a problem has arisen. Since the clinically important problem of RAS persists, we propose a completely different approach to mitigating this complication; i.e., electrical-induced relaxation of radial artery smooth muscle cells by use of electrified needle (e-needle). Our preliminary data show that the radial artery dilates in response to electrical stimulation with extracellular electrodes. This observation leads us to hypothesize that TRA devices can be transformed into vasodilating extracellular electrodes (with the return path provided by a skin patch electrode). Our aim is to assemble a prototype device and demonstrate its safety and efficacy in vivo in swine. The novel access e-needle will be used under ultrasound guidance to simultaneously measure radial artery diameter and assess prototype efficacy. Further, safety will be determined by measuring the electrocardiogram and arterial blood pressure during prototype use as well as histopathology after explanting the swine radial artery. Our novel approach to RAS promises to shift the current clinical paradigm from one of ad hoc attempts at pharmacological management (in which there is no consistency, but undesired side effects like hypotension) to one based on well-understood biophysical and biomedical engineering principles. Our project offers to improve patient care and save time for physicians with a novel TRA e-needle that dilates the artery it contacts the vessel for access. This will spare patients the pain of experiencing vasospasm, eliminate risks from unnecessary pharmacological agents, lower medical costs, and improve physician efficiency.

Public Health Relevance Statement:
NARRATIVE Percutaneous arterial catheterization, used in a wide variety of procedures including angiography and stent placement, is traditionally done through the femoral artery, but physicians are increasingly opting to use an artery in the wrist. This is a development for patients, who can quickly recover and walk out of the hospital the same day; however, radial access spasm is a frequent complication that is painful for patients and challenging for doctors. Our project is aimed at using safe and effective electrical stimulation through the access needle to relax the radial artery to enhance patient comfort, improve physician efficiency, and reduce health care costs.

Project Terms:
Address; Adopted; Adoption; Anatomy; Angiography; Arteries; base; Biomedical Engineering; Biophysics; Blood gas; Blood Pressure; Blood Vessels; Caliber; Cardiology; Carotid stent; Catheterization; Catheters; Clinical; Complication; Consumption; cost; Data; Development; Devices; Distal; Electric Stimulation; Electrocardiogram; Electrodes; Ensure; Equipment; Exhibits; experience; extracellular; Family suidae; femoral artery; fovea centralis; Goals; Guidelines; Hand; Health Care Costs; Health Insurance; Hemorrhage; Histopathology; Hospitals; Hypotension; Improve Access; improved; in vivo; Injury; Intervention; Lymphatic; Measures; Medical; Medical Care Costs; Medical Device; Medication Management; Medicine; Methods; Needles; novel; novel strategies; Outcome; Pain; Patient Care; Patients; Peripheral; Pharmaceutical Preparations; Pharmacological Treatment; Pharmacology; Phase; Physicians; Physiologic pulse; prevent; Prevention; Procedures; Protocols documentation; prototype; Radial; radial artery; Regimen; Relaxation; renal artery; response; Risk; Safety; Sampling; Seminal; side effect; skin patch; Small Business Innovation Research Grant; Smooth Muscle; Smooth Muscle Myocytes; Spasm; Stents; success; Techniques; Technology; Testing; Therapeutic; Therapeutic Uses; Thumb structure; Time; Training; Translating; treatment response; Ultrasonography; Vasodilation; Vasodilator Agents; Vasospasm; Walking; Workload; Wrist

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----